Connect with us
The blood-brain barrier is a major hurdle in treating a whole range of diseases affecting the CNS. While it serves a vital role in protecting against...
Stocks like BB Biotech should be treated with caution. Nevertheless, there is a quite realistic chance that investors will receive a higher dividend from BB Biotech....
Estimated as a $3 billion opportunity for Bioasis Technologies, the company's xB3 platform is set to revolutionize the treatment of neurological disease. The technology helps deliver...
Aortyx has received a $2.8 million (€2.5 million) grant from the European Commission. Prior to this investment, the company was already recognized and funded with more...
The negative variation of the Spanish pharmaceutical sector contrasts with the positive performance of the Ibex35, which recorded a rise of 8% at the close of...
The Spanish multinational Grifols, specialized in the production of blood products, has continued to expand its network with the launch of the first integrated plasma supply...
Moira Capital, based in Madrid, started its activity in early 2017 as a manager specialized in direct high-return investments for private investors and institutions. The company...
Currently the company Psious, according to the data provided, has more than 2,000 therapist clients, has treated more than 16,000 patients, has conducted more than 150,000...
Endolipid Therapeutics has developed a peptide platform. With this round, the company aims to cover development costs during 2022 to reach two milestones: licensing the anti-cellulite...
HempFusion’s management team walks us through the evolving health and wellness market. As a company positioned to expand beyond their base business to take advantage of...
 |
|
 |  |
 |
|